Search Results - nicolas+wyhs

2 Results Sort By:
C12052 - LAPC4-CR a Castration Resistant Human Prostate Cancer Cell Line
Novelty: New LAPC4-CR cell line which shows properties of castration resistant tumors, both in vitro and in vivo.Value Proposition: Current treatments for metastatic prostate cancer involve castration, resulting in low serum androgen levels. After intervention and treatment, most tumors develop resistance to this therapy and present as castration resistant...
Published: 3/13/2025   |   Inventor(s): Srinivasan Yegnasubramanian, Michael Haffner, William Nelson, Nicolas Wyhs
Keywords(s): Basic Research Biomarker, Cancers, Cell Lines, Discovery/Research Tools, Disease Indication, Human Cell Lines, In Vitro Research Tool, Mouse Cell Lines, Prostate Cancer
Category(s): Technology Classifications > Research Tools > Animal Models, Technology Classifications > Research Tools > Cell Lines, Technology Classifications > Research Tools, Clinical and Disease Specializations > Oncology > Prostate Cancer
C12051 - VCaP-CR a Castration Resistant Human Prostate Cancer Cell Line
Novelty: New VCaP-CR cell line that shows properties of castration resistant tumors, both in vitro and in vivo. Value Proposition: Current treatments for metastatic prostate cancer involve castration, resulting in low serum androgen levels. After intervention and treatment, most tumors develop resistance to this therapy and present as castration resistant...
Published: 3/13/2025   |   Inventor(s): Srinivasan Yegnasubramanian, Michael Haffner, William Nelson, Nicolas Wyhs
Keywords(s): Basic Research Biomarker, Cancers, Cell Lines, Discovery/Research Tools, Disease Indication, Human Cell Lines, In Vitro Research Tool, Prostate Cancer
Category(s): Technology Classifications > Research Tools > Cell Lines, Technology Classifications > Research Tools > Human Cell Lines, Technology Classifications > Research Tools, Clinical and Disease Specializations > Oncology > Prostate Cancer
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum